FERRI, NICOLA
 Distribuzione geografica
Continente #
NA - Nord America 10.851
EU - Europa 1.013
AS - Asia 518
SA - Sud America 7
AF - Africa 5
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.402
Nazione #
US - Stati Uniti d'America 10.848
IT - Italia 464
CN - Cina 399
FI - Finlandia 205
SE - Svezia 99
GB - Regno Unito 93
VN - Vietnam 64
DE - Germania 53
UA - Ucraina 16
FR - Francia 15
IE - Irlanda 14
NL - Olanda 14
PK - Pakistan 10
BE - Belgio 9
TW - Taiwan 8
IN - India 6
JP - Giappone 5
RO - Romania 5
BR - Brasile 4
GR - Grecia 4
HK - Hong Kong 4
KR - Corea 4
NP - Nepal 4
NZ - Nuova Zelanda 4
AT - Austria 3
CA - Canada 3
CL - Cile 3
EE - Estonia 3
EU - Europa 3
SG - Singapore 3
DK - Danimarca 2
EG - Egitto 2
ES - Italia 2
IL - Israele 2
KE - Kenya 2
LU - Lussemburgo 2
PH - Filippine 2
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
IQ - Iraq 1
IR - Iran 1
KZ - Kazakistan 1
MK - Macedonia 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 12.402
Città #
Fairfield 2.136
Woodbridge 1.395
Houston 1.106
Ashburn 853
Seattle 816
Ann Arbor 801
Cambridge 738
Wilmington 707
Chandler 408
San Diego 216
Medford 191
Princeton 191
Roxbury 171
Des Moines 152
Padova 150
Beijing 101
Boardman 93
Helsinki 87
Guangzhou 79
Nanjing 74
Dong Ket 63
Hebei 24
London 21
Shenyang 20
Milan 19
New York 19
Falls Church 18
Nanchang 15
Dublin 14
Kharkiv 14
Los Angeles 14
Ogden 13
Borås 12
Shanghai 12
Jiaxing 11
Phoenix 10
Tappahannock 9
Verona 9
Norwalk 8
Tianjin 8
Aprilia 7
Hounslow 7
Indiana 7
Jinan 7
Rockville 7
Rome 7
Sahiwal 7
Chicago 6
Chioggia 6
Acton 5
Chiswick 5
Mestrino 5
Taipei 5
Acqui Terme 4
Binasco 4
Chieti 4
Este 4
Groningen 4
Hong Kong 4
Kilburn 4
Larissa 4
Legnaro 4
Messina 4
Mountain View 4
Paris 4
Prescot 4
Boom 3
Cagliari 3
Chengdu 3
Florence 3
Haikou 3
Iasi 3
Kathmandu 3
Kunming 3
Lanzhou 3
Lappeenranta 3
Marghera 3
New Bedfont 3
Parma 3
Rovigo 3
Singapore 3
Southwark 3
Taranto 3
Ansbach 2
Bologna 2
Cairo 2
Caravaggio 2
Carentino 2
Chang-hua 2
Changsha 2
Cosenza 2
Denver 2
Duncan 2
Falkenstein 2
Giavera del Montello 2
Goyang-si 2
Hangzhou 2
Hefei 2
Islington 2
Isola del Giglio 2
Totale 11.016
Nome #
Pharmacokinetics interactions of monoclonal antibodies 141
Pharmacology of the New P2Y(12) Receptor Inhibitors: Insights on Pharmacokinetic and Pharmacodynamic Properties 132
An in vivo active 1,2,5-oxadiazole Pt(II) complex: A promising anticancer agent endowed with STAT3 inhibitory properties 124
17-AAG increases autophagic removal of mutant androgen receptor in spinal and bulbar muscular atrophy 115
Ajoene, a garlic compound, inhibits protein prenylation and arterial smooth muscle cell proliferation 115
AMP-activated protein kinase and the control of smooth muscle cell hyperproliferation in vascular disease 113
Everolimus inhibits monocyte/macrophage migration in vitro and their accumulation in carotid lesions of cholesterol-fed rabbits 112
Virtual screening approach for the identification of new Rac1 inhibitors 110
From lipoprotein apheresis to proprotein convertase subtilisin/kexin type 9 inhibitors: Impact on low-density lipoprotein cholesterol and C-reactive protein levels in cardiovascular disease patients 110
Efficacy and Safety of Mipomersen: A Systematic Review and Meta-Analysis of Randomized Clinical Trials 109
Peptidomimetic inhibitors of farnesyltransferase with high in vitro activity and significant cellular potency 108
Cytotoxic effect of (1-methyl-1H-imidazol-2-yl)-methanamine and its derivatives in PtII complexes on human carcinoma cell lines: A comparative study with cisplatin 106
A selective alpha1D-adrenoreceptor antagonist inhibits human prostate cancer cell proliferation and motility "in vitro" 105
Muscle cells and motoneurons differentially remove mutant SOD1 causing familial amyotrophic lateral sclerosis 105
Suppressor of Cytokine Signaling-3 (SOCS-3) induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) expression in hepatic HepG2 cell line 103
Identification of Ellagitannins in the Unripe Fruit of Rubus Chingii Hu and Evaluation of its Potential Antidiabetic Activity 102
3-Aryl-N-aminoylsulfonylphenyl-1H-pyrazole-5-carboxamides : a new class of selective Rac inhibitors 102
Long-term exposure to air pollution raises circulating levels of proprotein convertase subtilisin/kexin type 9 in obese individuals 101
Geranylgeraniol prevents the simvastatin-induced PCSK9 expression: role of the small G protein Rac1 100
Lipid Lowering Drugs and Inflammatory Changes: an Impact on Cardiovascular Outcomes? 100
Liver fat accumulation is associated with circulating PCSK9 levels 99
Aliskiren reduces prorenin receptor expression and activity in cultured human aortic smooth muscle cells 99
Nitric Oxide-Donating Atorvastatin Attenuates Neutrophil Recruitment During Vascular Inflammation Independent of Changes in Plasma Cholesterol 98
Simvastatin reduces MMP1 expression in human smooth muscle cells cultured on polymerized collagen by inhibiting RAC1 activation 98
Proprotein convertase subtilisin kexin type 9 and high-density lipoprotein metabolism: experimental animal models and clinical evidence 97
Non-lipid-related effects of statins 97
Upregulation of Lectin-Like Oxidized Low Density Lipoprotein Receptor 1 (Lox-1) Expression in Human Endothelial Cells by Modified High Density Lipoproteins 97
Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with Nonalcoholic fatty liver disease 97
Isothiazole dioxide derivative 6n inhibits vascular smooth muscle cell proliferation and protein farnesylation 97
Thematic review series : the immune system and atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease 95
Proprotein Convertase Subtilisin/Kexin Type 9, Brain Cholesterol Homeostasis and Potential Implication for Alzheimer's Disease 95
Integrin-mediated transcriptional activation of inhibitor of apoptosis proteins protects smooth muscle cells against apoptosis induced by degraded collagen 95
Differential Processing of α- and β-Defensin Precursors by Matrix Metalloproteinase-7 (MMP-7) 94
Plasma PCSK9 levels and lipoprotein distribution are preserved in carriers of genetic HDL disorders 94
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients 94
Differential effects of red yeast rice, Berberis aristata and Morus alba extracts on PCSK9 and LDL uptake 94
Synthesis, Structural and Biological Evaluation of Bis-Heteroarylmaleimides and Bis-Heterofused Imides 90
Direct vascular effects of HMG-CoA reductase inhibitors 90
Inhibitory effect of PCSK9 on Abca1 protein expression and cholesterol efflux in macrophages 88
L-Arginine prevents inflammatory and pro-calcific differentiation of interstitial aortic valve cells 88
Fluvastatin synergistically improves the antiproliferative effect of everolimus on rat smooth muscle cells by altering p27Kip1/cyclin E expression 87
Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) by 15-lipoxygenase-modified LDL in endothelial cells 86
PCSK9 Involvement in Aortic Valve Calcification 86
Angiopoietin-like 3 and subclinical peripheral arterial disease: Evidence from the Brisighella Heart Study 86
Disruption of ArhGAP15 results in hyperactive Rac1, affects the architecture and function of hippocampal inhibitory neurons and causes cognitive deficits 86
Ability of simvastatin to inhibit DNA synthesis in PDGF-BB-, EGF-, LPA- and ET-1- stimulated smooth muscle cells. 85
Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels 85
Dipeptide nanotubes containing unnatural fluorine-substituted β(2,3)-diarylamino acid and l-Alanine as candidates for biomedical applications 85
Synthetic peptides containing a conserved sequence motif of the Id protein family modulate vascular smooth muscle cell phenotype 85
Ruolo della fosfolipasi A2 secretoria e della fosfolipasi associata alle lipoproteine nel rischio cardiovascolare 85
Promising antiproliferative platinum(II) complexes based on imidazole moiety: synthesis, evaluation in HCT-116 cancer cell line and interaction with Ctr-1 Met-rich domain 84
Adipose tissue related adipokines and cytokines regulate PCSK9 expression in HepG2 cells 84
Peptide modulators of Rac1/Tiam1 protein-protein interaction: An alternative approach for cardiovascular diseases 84
Inhibition of smooth muscle cell migration and proliferation by statins 83
Simvastatin reduces MMP1 expression in human smooth muscle cells cultured on polymerized collagen by inhibiting Rac1 activation 83
Monofunctional PtII Complexes Based on 8-Aminoquinoline: Synthesis and Pharmacological Characterization 83
Chemotactic effect of prorenin on human aortic smooth muscle cells : a novel function of the (pro)renin receptor 82
Lipid-modified proteins as biomarkers for cardiovascular disease: a review 82
Farnesyltransferase inhibitors : CAAX mimetics based on different biaryl scaffolds 82
Changes in circulating pro-protein convertase subtilisin/kexin type 9 levels – experimental and clinical approaches with lipid-lowering agents 82
Antiproliferative effects on human tumor cells and rat aortic smooth muscular cells of 2,3-heteroarylmaleimides and heterofused imides 82
High Density Lipoproteins Inhibit Oxidative Stress-Induced Prostate Cancer Cell Proliferation 81
Development of poly(lactide-co-glycolide) nanoparticles functionalized with a mitochondria penetrating peptide 80
Cholesterol-Lowering Action of a Novel Nutraceutical Combination in Uremic Rats: Insights into the Molecular Mechanism in a Hepatoma Cell Line 80
Clinical approach to the inflammatory etiology of cardiovascular diseases 80
Cross-talk between EGFR and T-cadherin: EGFR activation promotes T-cadherin localization to intercellular contacts 79
Fibrillar collagen inhibits cholesterol biosynthesis in human aortic smooth muscle cells 79
Drug attrition during pre-clinical and clinical development : understanding and managing drug-induced cardiotoxicity 79
Clinical evidence of statin therapy in non-dyslipidemic disorders 79
Circulating Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and Arterial Stiffness in a Large Population Sample: Data From the Brisighella Heart Study 79
Role of discoidin domain receptors 1 and 2 in human smooth muscle cell-mediated collagen remodeling: potential implications in atherosclerosis and lymphangioleiomyomatosis 79
The brown algae fucus vesiculosus and ascophyllum nodosum reduce metabolic syndrome risk factors: A clinical study 78
Synthesis of new dithiolethione and methanethiosulfonate systems endowed with pharmaceutical interest 77
New Ras CAAX mimetics: Design, synthesis, antiproliferative activity, and RAS prenylation inhibition 77
Isothiazoles. Part XV. A mild and efficient synthesis of new antiproliferative 5-sulfanylsubstituted 3-alkylaminoisothiazole 1,1-dioxides 76
Human megakaryocytes confer tissue factor to a subset of shed platelets to stimulate thrombin generation 76
Aliskiren inhibits prorenin-induced human aortic smooth muscle cell migration 76
The small heat shock protein B8 (HSPB8) modulates proliferation and migration of breast cancer cells 76
Cleavage of focal adhesion kinase in vascular smooth muscle cells overexpressing membrane-type matrix metalloproteinases 75
Thiazole- and imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase 74
PCSK9 knock-out mice are protected from neointimal formation in response to perivascular carotid collar placement 74
PCSK9 induces a pro-inflammatory response in macrophages 74
Fucus vesiculosus and Ascophyllum nodosum Ameliorate Liver Function by Reducing Diet-Induced Steatosis in Rats 74
Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: new therapeutic approaches for the treatment of atherogenic dyslipidemia 74
SUPPRESSOR OF CYTOKINE SIGNALING-3 (SOCS-3) INDUCES PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9) EXPRESSION IN HEPATIC HEPG2 CELL LINE 73
In vitro anticancer activity evaluation of new cationic platinum(II) complexes based on imidazole moiety 73
Cytotoxic performances of new anionic cyclometalated Pt(II) complexes bearing chelated O^O ligands 73
Antiatherosclerotic activities of mibefradil in cell culture 72
Naturally occurring PDGF receptor inhibitors with potential anti-atherosclerotic properties 72
Left main coronary wall thickness correlates with the carotid intima media thickness and may provide a new marker of cardiovascular risk 71
Methanethiosulfonate derivatives as ligands of the STAT3-SH2 domain 70
Effects of polysaccharides from Inonotus obliquus and its chromium (III) complex on advanced glycation end-products formation, α-amylase, α-glucosidase activity and H2O2-induced oxidative damage in hepatic L02 cells 70
Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease 69
Liver fat accumulation is associated with circulating PCSK9 67
A field-based disparity analysis of new 1,2,5-oxadiazole derivatives endowed with antiproliferative activity 67
Bococizumab for the treatment of hypercholesterolaemia 67
Himalayan Nettle Girardinia diversifolia as a Candidate Ingredient for Pharmaceutical and Nutraceutical Applications-Phytochemical Analysis and In Vitro Bioassays 67
2-Amino-3-(phenylsulfanyl)norbornane-2-carboxylate: An Appealing Scaffold for the Design of Rac1-Tiam1 Protein-Protein Interaction Inhibitors 66
Effect of a novel nutraceutical combination on serum lipoprotein functional profile and circulating PCSK9 66
Fas and Fas-associated death domain protein regulate monocyte chemoattractant protein-1 expression by human smooth muscle cells through caspase- and calpain-dependent release of interleukin-1alpha 65
Totale 8.760
Categoria #
all - tutte 46.220
article - articoli 40.609
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 78
selected - selezionate 0
volume - volumi 129
Totale 87.036


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019803 0 0 0 0 0 0 0 0 0 0 445 358
2019/20202.656 336 116 28 151 286 173 249 293 327 309 198 190
2020/20212.544 177 368 131 268 104 93 94 337 293 253 262 164
2021/20222.625 133 257 326 186 124 113 128 296 138 78 231 615
2022/20231.348 347 20 14 123 261 151 25 109 182 14 77 25
2023/2024629 31 90 105 85 38 38 49 63 89 41 0 0
Totale 12.703